{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:10:47Z","timestamp":1781277047102,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The clinical relevance of pancreatic intraepithelial neoplasia (PanIN) at the resection margin of pancreatic ductal adenocarcinoma remains unknown. We aimed to investigate its clinical impact at the pancreatic transection margin (PTM) and, based on the result, determine the prognostic values of the resection margin status and other clinicopathologic parameters.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Patients and methods<\/jats:title>\n<jats:p>We retrospectively analyzed 122 consecutive patients who underwent pancreatoduodenectomy or distal pancreatectomy between 2006 and 2018. Pathologic slides were reviewed and survival data were retrieved from institutional databases. Associations between two variables were investigated by Fisher\u2019s exact test. Survival curves were generated by the Kaplan-Meier method. Prognostic factors were assessed using Cox regression analysis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Tumors were resected without leaving macroscopic remnants. The median follow-up period after surgery was 524.5\u2009days. Cancer-related death (<jats:italic>n<\/jats:italic> = 72) was marginally and significantly associated with local recurrence (<jats:italic>n<\/jats:italic> = 22) and distant metastasis (<jats:italic>n<\/jats:italic> = 79), respectively. Local recurrence and distant metastasis occurred independently. After excluding cases with invasive cancer at any other margin, PanIN-2 or PanIN-3 (<jats:italic>n<\/jats:italic> = 21) at the PTM did not adversely affect prognoses compared with normal mucosa or PanIN-1 (<jats:italic>n<\/jats:italic> = 57) with statistical significance. R0 resection (<jats:italic>n<\/jats:italic> = 78), which is invasive cancer-free at all resection margins, showed somewhat better local recurrence-free and overall survivals as compared with R1 resection (<jats:italic>n<\/jats:italic> = 44), which involves invasive cancer at any resection margin, but the differences did not reach statistical significance. In contrast, differentiation grade and nodal metastasis were significant predictors of distant metastasis, and tumor location and differentiation grade were significant predictors of cancer-related death. Although there was no significant difference in differentiation grade between the head cancer and the body or tail cancer, nodal metastasis was significantly more frequent in the former than in the latter.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>PanINs at the PTM did not adversely affect prognosis and R0 resection was not found to be a significant prognostic factor. Differentiation grade might be an indicator of occult metastasis and affect patients\u2019 overall survival through distant metastasis. In addition to successful surgical procedures, tumor biology may be even more important as a predictor of postoperative prognosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12957-020-01900-0","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T16:03:52Z","timestamp":1592841832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"18","author":[{"given":"Tsengelmaa","family":"Jamiyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"1900_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"key":"1900_CR2","unstructured":"American Cancer Society. Survival rates for pancreatic cancer https:\/\/www.cancer.org\/cancer\/pancreatic-cancer\/detection-diagnosis-staging\/survival-rates.html. Accessed 14 May 2019."},{"key":"1900_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s12885-018-4610-4","volume":"18","author":"AM Saad","year":"2018","unstructured":"Saad AM, Turk T, Al-Husseini MJ, Abdel-Rahman O. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer. 2018;18:688.","journal-title":"BMC Cancer"},{"key":"1900_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2217\/fon-2016-0010","volume":"12","author":"D Ansari","year":"2016","unstructured":"Ansari D, Tingstedt B, Andersson B, et al. Pancreativ cancer: yesterday, today, and tomorrow. Future Oncol. 2016;12:1929\u201346.","journal-title":"Future Oncol"},{"key":"1900_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/13651820310017093","volume":"6","author":"R Andersson","year":"2004","unstructured":"Andersson R, Vagianos CE, Williamson RC. Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma. HPB. 2004;6:5\u201312.","journal-title":"HPB"},{"key":"1900_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1365-2559.2007.02935.x","volume":"52","author":"CS Verbeke","year":"2008","unstructured":"Verbeke CS. Resection margins and R1 rates in pancreatic cancer - are we there yet? Histopathology. 2008;52:787\u201396.","journal-title":"Histopathology"},{"key":"1900_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.pap.0000155055.14238.25","volume":"12","author":"A Maitra","year":"2005","unstructured":"Maitra A, Fukushima N, Takaori K, Hruban RH. Precursors to invasive pancreatic cancer. Adv Anat Pathol. 2005;12:81\u201391.","journal-title":"Adv Anat Pathol"},{"key":"1900_CR8","first-page":"283","volume-title":"WHO classification of tumours of the digestive system","author":"RH Hruban","year":"2009","unstructured":"Hruban RH, Boffetta P, Hiraoka N, et al. Tumours of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2009. p. 283\u20138.","edition":"4"},{"key":"1900_CR9","doi-asserted-by":"crossref","unstructured":"Pancreas. In: Brierley JD, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumours, 8th. West Sussex: Wiley, 2017: 102-4.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"1900_CR10","first-page":"68","volume-title":"Classification of pancreatic carcinoma","author":"Japan Pancreas Society","year":"2017","unstructured":"Japan Pancreas Society. Classification of pancreatic carcinoma. 4th ed. Tokyo: Kanehara; 2017. p. 68.","edition":"4"},{"key":"1900_CR11","volume-title":"Dataset for the histological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct","author":"The Royal College of Pathologists","year":"2017","unstructured":"The Royal College of Pathologists. Dataset for the histological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct. London: The Royal College of Pathologists; 2017. https:\/\/www.rcpath.org\/uploads\/assets\/34910231-c106-4629-a2de9e9ae6f87ac1\/g091-pancreasdataset-mar17.pdf. Accessed 5 Jul 2019."},{"key":"1900_CR12","unstructured":"College of American Pathologists. Protocol for the examination of specimens from patients with carcinoma of the pancreas. Version: Pancreas Exocrine 4.0.0.0 https:\/\/www.cap.org\/protocols-and-guidelines\/cancer-reporting-tools\/cancer-protocol-templates. Accessed 5 Jul 2019."},{"key":"1900_CR13","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321:1801\u20136.","journal-title":"Science"},{"key":"1900_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","volume":"491","author":"AV Biankin","year":"2012","unstructured":"Biankin AV, Waddell N, Kassahn KS, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012;491:399\u2013405.","journal-title":"Nature"},{"key":"1900_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518:495\u2013501.","journal-title":"Nature"},{"key":"1900_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7150\/ijbs.14995","volume":"12","author":"J Guo","year":"2016","unstructured":"Guo J, Xie K, Zheng S. Molecular biomarkers of pancreatic intraepithelial neoplasia and their implications in early diagnosis and therapeutic intervention of pancreatic cancer. Int J Biol Sci. 2016;12:292\u2013301.","journal-title":"Int J Biol Sci"},{"key":"1900_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/path.5154","volume":"246","author":"CG Fischer","year":"2018","unstructured":"Fischer CG, Wood LD. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions. J Pathol. 2018;246:395\u2013404.","journal-title":"J Pathol"},{"issue":"Suppl 1","key":"1900_CR18","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1038\/modpathol.3800685","volume":"20","author":"RH Hruban","year":"2007","unstructured":"Hruban RH, Fukushima N. Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs. Mod Pathol. 2007;20(Suppl 1):S61\u201370.","journal-title":"Mod Pathol"},{"key":"1900_CR19","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1245\/s10434-011-1745-9","volume":"18","author":"H Matthaei","year":"2011","unstructured":"Matthaei H, Hong SM, Mayo SC, et al. Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol. 2011;18:3493\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1900_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","volume":"25","author":"RH Hruban","year":"2001","unstructured":"Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25:579\u201386.","journal-title":"Am J Surg Pathol"},{"key":"1900_CR21","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1245\/s10434-013-3042-2","volume":"20","author":"IT Konstantinidis","year":"2013","unstructured":"Konstantinidis IT, Vinuela EF, Tang LH, et al. Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance? Ann Surg Oncol. 2013;20:3643\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1900_CR22","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1365-2559.2011.04056.x","volume":"59","author":"CS Verbeke","year":"2011","unstructured":"Verbeke CS, Knapp J, Gladhaug IP. Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment. Histopathology. 2011;59:1111\u201321.","journal-title":"Histopathology"},{"key":"1900_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archsurg.2012.1126","volume":"147","author":"JL Gnerlich","year":"2012","unstructured":"Gnerlich JL, Luka SR, Deshpande AD, et al. Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma. Arch Surg. 2012;147:753\u201360.","journal-title":"Arch Surg"},{"key":"1900_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4143\/crt.2016.336","volume":"49","author":"KS Kim","year":"2017","unstructured":"Kim KS, Kwon J, Kim K, Chie EK. Impact of resection margin distance on survival of pancreatic cancer: a systematic review and meta-analysis. Cancer Res Treat. 2017;49:824\u201333.","journal-title":"Cancer Res Treat"},{"key":"1900_CR25","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1245\/s10434-018-6467-9","volume":"25","author":"S van Roessel","year":"2018","unstructured":"van Roessel S, Kasumova GG, Tabatabaie O, et al. Pathological margin clearance and survival after pancreaticoduodenectomy in a US and European pancreatic center. Ann Surg Oncol. 2018;25:1760\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1900_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/archsurg.2007.17","volume":"143","author":"G Butturini","year":"2008","unstructured":"Butturini G, Stocken DD, Wente MN, et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg. 2008;143:75\u201383 discussion 83.","journal-title":"Arch Surg"},{"key":"1900_CR27","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.surg.2013.04.015","volume":"154","author":"T Sugiura","year":"2013","unstructured":"Sugiura T, Uesaka K, Mihara K, et al. Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer. Surgery. 2013;154:1078\u201386.","journal-title":"Surgery"},{"key":"1900_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00268-014-2808-4","volume":"39","author":"F Gebauer","year":"2015","unstructured":"Gebauer F, Tachezy M, Vashist YK, et al. Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic? World J Surg. 2015;39:493\u20139.","journal-title":"World J Surg"},{"key":"1900_CR29","unstructured":"College of American Pathologists. Protocol for the examination of specimens from patients with carcinoma of the pancreas. Version: PancreasExocrine 3.4.0.0 https:\/\/www.cap.org\/protocols-and-guidelines\/cancer-reporting-tools\/cancer-protocol-templates. Accessed 5 Jul 2019."},{"key":"1900_CR30","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1200\/JCO.2008.20.5104","volume":"27","author":"DK Chang","year":"2009","unstructured":"Chang DK, Johns AL, Merrett ND, et al. Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol. 2009;27:2855\u201362.","journal-title":"J Clin Oncol"},{"key":"1900_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0002-9610(05)80406-4","volume":"165","author":"RJ Geer","year":"1993","unstructured":"Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993;165:68\u201372 discussion 72-3.","journal-title":"Am J Surg"},{"key":"1900_CR32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S1091-255X(00)80105-5","volume":"4","author":"TA Sohn","year":"2000","unstructured":"Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567\u201379.","journal-title":"J Gastrointest Surg"},{"key":"1900_CR33","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jamcollsurg.2004.01.008","volume":"198","author":"SP Cleary","year":"2004","unstructured":"Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg. 2004;198:722\u201331.","journal-title":"J Am Coll Surg"},{"key":"1900_CR34","first-page":"346","volume":"26","author":"S Chakraborty","year":"2013","unstructured":"Chakraborty S, Singh S. Surgical resection improves survival in pancreatic cancer patients without vascular invasion - a population based study. Ann Gastroenterol. 2013;26:346\u201352.","journal-title":"Ann Gastroenterol"},{"issue":"1 Suppl","key":"1900_CR35","first-page":"132","volume":"8","author":"G Barugola","year":"2007","unstructured":"Barugola G, Falconi M, Bettini R, et al. The determinant factors of recurrence following resection for ductal pancreatic cancer. JOP. 2007;8(1 Suppl):132\u201340.","journal-title":"JOP"},{"key":"1900_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/SLA.0b013e3181613142","volume":"247","author":"T Schnelldorfer","year":"2008","unstructured":"Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 2008;247:456\u201362.","journal-title":"Ann Surg"},{"key":"1900_CR37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/MPA.0b013e3181bd6489","volume":"39","author":"MK Lau","year":"2010","unstructured":"Lau MK, Davila JA, Shaib YH. Incidence and survival of pancreatic head and body and tail cancers: apopulation-based study in the United States. Pancreas. 2010;39:458\u201362.","journal-title":"Pancreas"},{"key":"1900_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1072-7515(99)00075-7","volume":"189","author":"SF Sener","year":"1999","unstructured":"Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985\u20131995, using the National Cancer Database. J Am Coll Surg. 1999;189:1\u20137.","journal-title":"J Am Coll Surg"},{"key":"1900_CR39","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1002\/bjs.10772","volume":"105","author":"SB Dreyer","year":"2018","unstructured":"Dreyer SB, Jamieson NB, Upstill-Goddard R, et al. Defining the molecular pathology of pancreatic body and tail adenocarcinoma. Br J Surg. 2018;105:e183\u201391.","journal-title":"Br J Surg"},{"key":"1900_CR40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/cancers11040497","volume":"11","author":"DJ Birnbaum","year":"2019","unstructured":"Birnbaum DJ, Bertucci F, Finetti P, Birnbaum D, Mamessier E. Head and body\/tail pancreatic carcinomas are not the same yumors. Cancers. 2019;11:497.","journal-title":"Cancers"},{"key":"1900_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jamcollsurg.2006.11.002","volume":"204","author":"SM Strasberg","year":"2007","unstructured":"Strasberg SM, Linehan DC, Hawkins WG. Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg. 2007;204:244\u20139.","journal-title":"J Am Coll Surg"},{"key":"1900_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/01.mpa.0000194609.24606.4b","volume":"32","author":"HJ Moon","year":"2006","unstructured":"Moon HJ, An JY, Heo JS, Choi SH, Joh JW, Kim YI. Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. Pancreas. 2006;32:37\u201343.","journal-title":"Pancreas"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-020-01900-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:22:19Z","timestamp":1624317739000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-020-01900-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1186\/s12957-020-01900-0","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"21 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional ethical committees. Due to the retrospective study design and the anonymization of data, consent to participate was not necessary.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}